problems with glp-1 drugs Part 2 of a 3-Part Series; Medications for Weight Loss As GLP-1 drugs continue to

As new uses emerge, companies must carefully monitor patient health and integrate behavior change strategies

Rotate placement daily to keep skin happy

Looking ahead, the influence of US policy and Most Favoured Nation (international reference) pricing will remain a central trend that shaped obesity care in 2025 and will continue to do so into 2026 and beyond

Ozempic (semaglutide) is a medication used to manage type 2 diabetes

Official supply shortages persisted for most of 2024, as surging demand for AOMs continued to outstrip product supply, despite limited reimbursement, which presented an opportunity quickly seized upon by U.S